Cargando…

High expression of PARD3 predicts poor prognosis in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the most commonly cancers with poor prognosis and drug response. Identifying accurate therapeutic targets would facilitate precision treatment and prolong survival for HCC. In this study, we analyzed liver hepatocellular carcinoma (LIHC) RNA sequencing (RNA-s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Songwei, Huang, Jian, Yang, Fan, Zeng, Haiping, Tong, Yuyun, Li, Kejia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154901/ https://www.ncbi.nlm.nih.gov/pubmed/34040099 http://dx.doi.org/10.1038/s41598-021-90507-w

Ejemplares similares

High Expression of POGK Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
por: Xu, Wenxiong, et al.
Publicado: (2022)

miR-559 Inhibits Proliferation, Autophagy, and Angiogenesis of Hepatocellular Carcinoma Cells by Targeting PARD3
por: Wang, Chunjing, et al.
Publicado: (2022)

Decreased CRHBP expression is predictive of poor prognosis in patients with hepatocellular carcinoma
por: Xia, Hai-Bing, et al.
Publicado: (2018)

High-frequency oscillatory ventilation for PARDS: awaiting PROSPect
por: Kneyber, Martin C. J., et al.
Publicado: (2020)

High expression of GNA13 is associated with poor prognosis in hepatocellular carcinoma
por: Xu, Yi, et al.
Publicado: (2016)

Highly expressed FAM189B predicts poor prognosis in hepatocellular carcinoma
por: Ma, Wanshan, et al.
Publicado: (2022)

Upregulation of RECQL4 expression predicts poor prognosis in hepatocellular carcinoma
por: Li, Jun, et al.
Publicado: (2018)

High miR-454-3p expression predicts poor prognosis in hepatocellular carcinoma
por: Li, Yanqing, et al.
Publicado: (2019)

Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma
por: ZHANG, ZHEN-HAI, et al.
Publicado: (2014)

High TGF-β1 expression predicts poor disease prognosis in hepatocellular carcinoma patients
por: Peng, Li, et al.
Publicado: (2017)

High Expression of SLC41A3 Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Li, Qian, et al.
Publicado: (2021)

High USP22 expression indicates poor prognosis in hepatocellular carcinoma
por: Tang, Bo, et al.
Publicado: (2015)

High expression of TACC2 in hepatocellular carcinoma is associated with poor prognosis
por: Shakya, Manjul, et al.
Publicado: (2018)

Up-regulated and interrelated expressions of GINS subunits predict poor prognosis in hepatocellular carcinoma
por: Lian, Yi-Fan, et al.
Publicado: (2018)

High KIAA1522 expression predicts a poor prognosis in patients with hepatocellular carcinoma
por: Xu, Yongzheng, et al.
Publicado: (2020)

High expression of RPL27A predicts poor prognosis in patients with hepatocellular carcinoma
por: Xing, Huiwu, et al.
Publicado: (2023)

High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinoma
por: Liao, Rui, et al.
Publicado: (2013)

High Expression of FLOT1 Is Associated with Progression and Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Shi-Hong, et al.
Publicado: (2013)

Partition-Defective 3 (PARD3) Regulates Proliferation, Apoptosis, Migration, and Invasion in Esophageal Squamous Cell Carcinoma Cells
por: Wang, Lei, et al.
Publicado: (2017)

Positive expression of ZNF689 indicates poor prognosis of hepatocellular carcinoma
por: Yi, Peng Sheng, et al.
Publicado: (2018)

High serum soluble CD155 level predicts poor prognosis and correlates with an immunosuppressive tumor microenvironment in hepatocellular carcinoma
por: Jin, An‐Li, et al.
Publicado: (2022)

CXCL17 Expression Predicts Poor Prognosis and Correlates with Adverse Immune Infiltration in Hepatocellular Carcinoma
por: Li, Li, et al.
Publicado: (2014)

Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients
por: Ruan, Jian, et al.
Publicado: (2016)

High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma
por: Mu, Wei, et al.
Publicado: (2022)

Parafibromin Is Highly Expressed in Hepatocellular Carcinoma and Its Expression Correlates with Poor Prognosis
por: Kim, Min-Kyung
Publicado: (2022)

Impact of HFOV in pARDS outcomes: questions remain
por: Kanthimathinathan, Hari Krishnan, et al.
Publicado: (2020)

Impact of CRRT in Patients with PARDS Treated with VV-ECMO
por: Redant, Sébastien, et al.
Publicado: (2021)

High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy
por: Wang, Haoyuan, et al.
Publicado: (2014)

High expression of miR-21 is not a predictor of poor prognosis in all patients with hepatocellular carcinoma
por: Yi, Peng Sheng, et al.
Publicado: (2018)

Decreased Expression of TMEM173 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
por: Bu, Yang, et al.
Publicado: (2016)

Multilevel regulation of RUVBL2 expression predicts poor prognosis in hepatocellular carcinoma
por: Yan, Tao, et al.
Publicado: (2019)

Decreased DC-SIGNR expression in hepatocellular carcinoma predicts poor patient prognosis
por: Xia, Hai-Bing, et al.
Publicado: (2020)

B4GALT5 high expression associated with poor prognosis of hepatocellular carcinoma
por: Han, Yang, et al.
Publicado: (2022)

Increased Expression of CAP2 Indicates Poor Prognosis in Hepatocellular Carcinoma()()
por: Fu, Jia, et al.
Publicado: (2015)

Highly expressed RPLP2 inhibits ferroptosis to promote hepatocellular carcinoma progression and predicts poor prognosis
por: Guo, Jiaxing, et al.
Publicado: (2023)

Increased expression of G9A contributes to carcinogenesis and indicates poor prognosis in hepatocellular carcinoma
por: Qin, Jian, et al.
Publicado: (2018)

High expression of FOXO3 is associated with poor prognosis in patients with hepatocellular carcinoma
por: Song, Shu-Shu, et al.
Publicado: (2020)

Eg5 Overexpression Is Predictive of Poor Prognosis in Hepatocellular Carcinoma Patients
por: Liu, Can, et al.
Publicado: (2017)

NSUN5 promotes progression and predicts poor prognosis in hepatocellular carcinoma
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)

Increased expression of urotensin II is associated with poor prognosis in hepatocellular carcinoma
por: Liu, Dian-Gang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nmlukeibop0tosflfoqs5lhvoi